Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA sore or scratchy throat can appear during Wegovy treatment, though it is not listed among the medicine's most common side effects. Semaglutide's well-documented side-effect profile is strongly gastrointestinal — nausea, reflux, burping — and it is often those upper-GI changes, rather than a direct effect on throat tissue, that people notice as throat discomfort. If you are asking because your throat has been uncomfortable since starting or increasing your dose, you are not imagining it. There are a few plausible explanations worth understanding, and knowing which one applies to you shapes what you should do next. Wegovy is a prescription-only medicine; a prescriber reviews your suitability before treatment begins and stays available if questions come up afterwards.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is no, not directly. The UK NHS patient information for semaglutide describes the side-effect profile as predominantly gastrointestinal: nausea, vomiting, diarrhoea, constipation, stomach pain, burping and acid reflux sit at the top of the list. A sore throat in the classic infectious sense (inflamed tonsils, fever, lymph nodes) does not appear as a named effect of semaglutide at any dose.
That said, the upper-GI effects can travel. Acid that reaches the back of the throat causes a soreness many people describe exactly as a sore throat, even when there is no infection present. Reflux-related throat irritation tends to be worst in the morning, after lying down, or shortly after eating. If yours fits that pattern, the underlying cause is likely oesophageal rather than immunological.
Burping is another under-discussed Wegovy effect. Semaglutide slows gastric emptying significantly, which can cause gas to build and then rise. Repeated burping pushes stomach acid and gas past the vocal cords and into the pharynx; over a day or two, that irritation accumulates. Our clinical team at nume sees this pattern raised fairly regularly by people who started treatment recently.
Quite possibly. One of the effects many people notice in the first weeks on Wegovy is a sharp drop in appetite, and with it, a drop in how much they drink. Food contains a surprisingly large share of daily fluid intake; eat less, drink less without realising it. The result can be a dry, slightly swollen feeling at the back of the throat that is easy to mistake for the early stages of a cold.
This is worth thinking about if your sore throat is worse later in the day, not accompanied by a runny nose or fever, and eases after drinking a large glass of water. Actively tracking fluid intake during the first month or two of treatment is something prescribers at nume, sorry, at
Actively tracking fluid intake during the first month or two of treatment is something prescribers at our consultation service often recommend unprompted, precisely because dehydration is easy to miss when appetite suppressants are doing their job. Aim for around 1.5–2 litres of water daily alongside treatment, though your prescriber or pharmacist can give you a more personalised steer.
If you are on a dose increase (moving from 0.5mg to 1mg, for example) side effects including the GI effects that can irritate the throat often briefly intensify. That timing is informative. A flare of throat discomfort that coincides neatly with a step-up in dose and settles within one to two weeks is a different clinical picture from a throat that has been progressively worsening for a month.
Most throat discomfort linked to reflux or dehydration resolves without intervention, or responds to straightforward measures: staying well hydrated, keeping the head of the bed slightly elevated overnight, eating smaller portions more slowly, and avoiding lying down within a couple of hours of eating. These are the same steps recommended for managing Wegovy's GI side effects more broadly, covered in more detail on our Wegovy treatment guide.
There are circumstances, though, where throat symptoms need professional eyes sooner rather than later. Contact your GP or prescriber if your sore throat is severe or has not improved after two weeks, if you have difficulty swallowing or a feeling that something is stuck, if you notice voice changes that are not settling, or if the sore throat is accompanied by shortness of breath or a rash. For a closer look at how Wegovy can affect the throat more broadly, including why certain symptoms develop and what they tend to mean, our dedicated page walks through the detail. If you ever suspect an allergic reaction (hives, facial swelling, difficulty breathing) treat it as an emergency and call 999.
You can also report any suspected side effect of Wegovy directly through the MHRA's Yellow Card scheme. This is open to patients as well as healthcare professionals and helps the MHRA build a fuller picture of how medicines behave in routine clinical use. Wegovy carries a Black Triangle (▼) status in the UK, meaning additional reporting is especially encouraged.
For most people, yes. The GI side effects of semaglutide, including any upper-GI irritation that reaches the throat, tend to be most noticeable in the early weeks and after each dose increase, then gradually settle as the body adjusts. Clinical trial data from the STEP 1 study, published in the New England Journal of Medicine, showed that gastrointestinal side effects led to discontinuation in a small minority of participants, the majority managed through the adjustment period.
If you are in the middle of that early phase, it can help to remember that the discomfort is typically self-limiting. A question our prescribers hear fairly often, particularly from people who started treatment mid-month when their budget lined up, is whether they need to stop the pen entirely. The answer is rarely yes. Slowing the titration schedule (staying at a lower dose for an extra four weeks rather than stepping up) is a recognised and legitimate approach, and one your prescriber can authorise. That is not the same as stopping. For more background on how semaglutide works and what to expect across the course of treatment, our semaglutide overview covers the mechanism and the evidence in one place.
If throat dryness specifically is your main concern, there is a dedicated look at that experience in our piece on dry throat on Wegovy, and for people whose throat soreness sits more towards pain, our guide covering what causes a sore throat on Wegovy goes further into management and red flags, while the Wegovy throat pain guide goes further into management and red flags.
Speak to our prescribers if you would like a clinical view of your specific symptoms in the context of your treatment, that conversation is part of the aftercare included with every nume prescription.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.